Skip to main content


IRB Barcelona aims to stimulate an entrepreneurial spirit among its researchers, thus facilitating technology transfer and promoting the creation of spin-offs. Since it was founded, the Institute has generated 7 spin-off companies, of which 6 are currently active. Altogether, the spin-offs have raised over 65M EUR.

Nuage Therapeutics was incorporated in 2021 with the mission to leverage chemical biology and biomolecular condensation to develop selective drugs…

Gate2Brain was founded in 2020 as a result of research devoted to peptides with the capacity to cross the Blood-Brain Barrier (BBB) and…

Ona Therapeutics was launched in 2019 and is specialised in the discovery and development of therapeutic biologics targeting tumour…

Nostrum Biodiscovery is a biotech company that was founded in 2015.

Inbiomotion is a Barcelona-based company dedicated to personalised medicine that was set up in 2011.

Accure Therapeutics was created in 2020 to boost two existing companies in CNS.

Omnia Molecular was launched in 2006 and suspended activity in 2016.